Optimisation of signal processing and electrical stimulation algorithms for the abatement of epileptic seizures. Epilepsy is the second-most common neurological disorder behind stroke and ischemic attacks, affecting 1-2 per cent of the nation's population. Pharmaceutical therapies are ineffective in approximately one third of cases, the result being a large unmet need for novel treatments. The devices to be produced through this project will improve the quality of life of many patients in the fu ....Optimisation of signal processing and electrical stimulation algorithms for the abatement of epileptic seizures. Epilepsy is the second-most common neurological disorder behind stroke and ischemic attacks, affecting 1-2 per cent of the nation's population. Pharmaceutical therapies are ineffective in approximately one third of cases, the result being a large unmet need for novel treatments. The devices to be produced through this project will improve the quality of life of many patients in the future and alleviate their dependence on traditional medications. The devices will also reduce the patients' requirements for medical practitioners, hospital and ambulance services, and will therefore also reduce the financial burden that neurological and epilepsy patients place on the community.Read moreRead less
Increasing the utility of tetanus toxins by protein engineering. There are a variety of common diseases that are the result of muscular defects. Some of these may be able to be treated with an agent that increases muscle tone, thereby giving benefit to the patient in the alleviation of symptoms. This project aims to use some of the most potent substances known, bacterial toxins, and engineer them to be valuable agents for treatment of certain muscular disorders.
Brain sodium channel: functional role of developmentally regulated alternative splicing. This project will identify the roles of neonatal and adult forms of a sodium channel in the function of neurons in the developing brain. Sodium channels are vital for brain function and this study will improve our understanding of the function of healthy brain as well as of underlying mechanisms of some neurological disorders.
Investigating the neuroprotective actions of metallo-complexes. Metal-based drugs offer an exciting new approach to treatment of neurodegeneration. However, little is known about how cells metabolise these drugs: information that is critical for further drug development. This project will determine how metal-based drugs are metabolized by neuronal cells and how this may result in therapeutic benefit.
Gene-environment interactions mediating experience-dependent plasticity in the healthy and diseased brain. The aim of this project is to understand how genes and environment combine to affect susceptibility to various brain disorders, using models of human diseases and manipulating environmental factors such as mental and physical activity. The project's focus is on neurological and psychiatric disorders, including Huntington's disease, depression, schizophrenia and autism.
Deciphering the cellular defences against aggregating proteins in human disease. Cells have inbuilt defences for coping with proteins that bend into abnormal sticky shapes that form toxic clusters. In many diseases, including Huntington's, the clusters severely damage nerve cells. This project will identify the genes and mechanisms cells use to protect themselves from toxic clusters, which could provide new therapeutic targets.